Yoichi Iwanaga

696 total citations
13 papers, 590 citations indexed

About

Yoichi Iwanaga is a scholar working on Molecular Biology, Immunology and Ophthalmology. According to data from OpenAlex, Yoichi Iwanaga has authored 13 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Ophthalmology. Recurrent topics in Yoichi Iwanaga's work include T-cell and Retrovirus Studies (4 papers), Microtubule and mitosis dynamics (3 papers) and Genomics and Chromatin Dynamics (2 papers). Yoichi Iwanaga is often cited by papers focused on T-cell and Retrovirus Studies (4 papers), Microtubule and mitosis dynamics (3 papers) and Genomics and Chromatin Dynamics (2 papers). Yoichi Iwanaga collaborates with scholars based in United States, Japan and Australia. Yoichi Iwanaga's co-authors include Kuan‐Teh Jeang, Takefumi Kasai, Hidekatsu Iha, Kuan-Teh Jeang, Jean‐Marie Péloponèse, Yan Li, Robert Benezra, Jerrold M. Ward, Sergey Sheleg and Akiko Miyazato and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Yoichi Iwanaga

13 papers receiving 575 citations

Peers

Countries citing papers authored by Yoichi Iwanaga

Since Specialization

Citations

This map shows the geographic impact of Yoichi Iwanaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Iwanaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Iwanaga more than expected).

Fields of papers citing papers by Yoichi Iwanaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichi Iwanaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Iwanaga. The network helps show where Yoichi Iwanaga may publish in the future.

Co-authorship network of co-authors of Yoichi Iwanaga

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichi Iwanaga. A scholar is included among the top collaborators of Yoichi Iwanaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichi Iwanaga. Yoichi Iwanaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	[Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease]. 2010 ·PubMed ·Hiroyuki Tanaka, Sunao Sugita, Yukiko Yamada, Tatsushi Kawaguchi, Yoichi Iwanaga, Koju Kamoi, (unknown), Hiroshi Takase, Manabu Mochizuki	11
2	Macular retinal detachment associated with peripapillary detachment in pathologic myopia 2007 ·International Ophthalmology ·Noriaki Shimada, Kyoko Ohno‐Matsui, Yoichi Iwanaga, Takashi Tokoro, Manabu Mochizuki	12
3	Heterozygous Deletion of Mitotic Arrest–Deficient Protein 1 (MAD1) Increases the Incidence of Tumors in Mice 2007 ·Cancer Research ·Yoichi Iwanaga, Ya‐Hui Chi, Akiko Miyazato, Sergey Sheleg, Kerstin Haller, Jean‐Marie Péloponèse, Yan Li, Jerrold M. Ward, Robert Benezra, Kuan‐Teh Jeang	146
4	Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2 2006 ·Rheumatology International ·Tae‐Hwan Kim, (unknown), Xiang Zhang, Yoichi Iwanaga, Michael P. Davey, James T. Rosenbaum, Robert D. Inman	14
5	Ku protein as a potential human T-cell leukemia virus type 1 (HTLV-1) Tax target in clastogenic chromosomal instability of mammalian cells 2005 ·Retrovirology ·Franca Majone, Roberto Luisetto, (unknown), Yoichi Iwanaga, Kuan‐Teh Jeang	31
6	Spondylodiscitis: diagnosis and treatment 2005 ·Surgical Neurology ·Shunji Asamoto, Hiroshi Doi, (unknown), (unknown), (unknown), Yoichi Iwanaga, Masahiro Ida, (unknown)	33
7	With a mere nod, uveitis enters a new era 2003 ·American Journal of Ophthalmology ·James T. Rosenbaum, Stephen R. Planck, Michael P. Davey, Yoichi Iwanaga, Daryl E. Kurz, Tammy M. Martin	11
8	Cloning, sequencing and expression analysis of the mouse NOD2/CARD15 gene 2003 ·Inflammation Research ·Yoichi Iwanaga, Michael P. Davey, Tammy M. Martin, Stephen R. Planck, (unknown), (unknown), (unknown), James T. Rosenbaum	43
9	Prevalent Loss of Mitotic Spindle Checkpoint in Adult T-cell Leukemia Confers Resistance to Microtubule Inhibitors 2002 ·Journal of Biological Chemistry ·Takefumi Kasai, Yoichi Iwanaga, Hidekatsu Iha, Kuan‐Teh Jeang	98
10	Characterization of Regions in hsMAD1 Needed for Binding hsMAD2 2002 ·Journal of Biological Chemistry ·Yoichi Iwanaga, Takefumi Kasai, Karen V. Kibler, Kuan-Teh Jeang	39
11	Expression of mitotic spindle checkpoint protein hsMAD1 correlates with cellular proliferation and is activated by a gain-of-function p53 mutant. 2002 ·PubMed ·Yoichi Iwanaga, Kuan‐Teh Jeang	37
12	Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation 2001 ·Oncogene ·Patrick Ng, Hidekatsu Iha, Yoichi Iwanaga, M. Bittner, Yidong Chen, Yuan Jiang, Gerald Gooden, Jeffrey M. Trent, Paul S. Meltzer, Kuan-Teh Jeang, Steven L. Zeichner	91
13	Pleiotropic Effects of HTLV Type 1 Tax Protein on Cellular Metabolism: Mitotic Checkpoint Abrogation and NF- κ B Activation 2000 ·AIDS Research and Human Retroviruses ·Hidekatsu Iha, Takefumi Kasai, Karen V. Kibler, Yoichi Iwanaga, Kunio Tsurugi, Kuan‐Teh Jeang	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact